N. Latysheva

发表

Associations between complement pathways activity, mannose-binding lectin, and odds of unprovoked venous thromboembolism.

J. Hansen, T. Mollnes, K. Hindberg, 2018, Thrombosis research.

Plasma lipopolysaccharide‐binding protein is a biomarker for future venous thromboembolism: Results from discovery and validation studies

T. Ueland, K. Hindberg, N. Latysheva, 2022, Journal of internal medicine.

A modified clot-based assay to measure negatively charged procoagulant phospholipids

J. Hansen, O. Snir, T. Sovershaev, 2021, Scientific Reports.

Impact of preanalytical conditions on plasma concentration and size distribution of extracellular vesicles using Nanoparticle Tracking Analysis

J. Hansen, P. Webster, S. Brækkan, 2018, Scientific Reports.

A rapid, sensitive, and specific assay to measure TF activity based on chromogenic determination of thrombin generation

J. Hansen, B. Jilma, O. Snir, 2021, Journal of thrombosis and haemostasis : JTH.

Effect of lower‐leg trauma and knee arthroscopy on procoagulant phospholipid‐dependent activity

J. Hansen, R. Nelissen, S. Cannegieter, 2022, Research and practice in thrombosis and haemostasis.

Tumour Microenvironments Induce Expression of Urokinase Plasminogen Activator Receptor (uPAR) and Concomitant Activation of Gelatinolytic Enzymes

T. Salo, S. Steigen, G. Svineng, 2014, PloS one.

Plasma levels of platelet‐derived microvesicles are associated with risk of future venous thromboembolism

J. Hansen, S. Braekkan, O. Snir, 2022, Journal of thrombosis and haemostasis : JTH.

Identification of Common and Rare Genetic Variation Associated With Plasma Protein Levels Using Whole-Exome Sequencing and Mass Spectrometry

William W. Greenwald, K. Frazer, Erin N. Smith, 2018, Circulation. Genomic and precision medicine.

Differential expression of plasma miRNAs in patients with unprovoked venous thromboembolism and healthy control individuals.

T. Blondal, J. Hansen, A. Sorrentino, 2015, Thrombosis research.

Complement factors B, D, C3bBbP and risk of future venous thromboembolism.

J. Hansen, T. Ueland, O. Snir, 2023, Clinical immunology.

Plasma procoagulant phospholipid clotting time and venous thromboembolism risk

J. Hansen, O. Snir, S. Brækkan, 2021, Research and practice in thrombosis and haemostasis.

Complement activation assessed by the plasma terminal complement complex and future risk of venous thromboembolism

J. Hansen, T. Ueland, O. Snir, 2019, Journal of thrombosis and haemostasis : JTH.

Elevated plasma D-dimer levels are associated with risk of future incident venous thromboembolism.

J. Hansen, T. Ueland, P. Aukrust, 2021, Thrombosis research.

Plasma levels of growth differentiation factor 15 are associated with future risk of venous thromboembolism.

J. Hansen, T. Ueland, P. Aukrust, 2020, Blood.

Discovery of novel plasma biomarkers for future incident venous thromboembolism by untargeted synchronous precursor selection mass spectrometry proteomics

K. Frazer, J. Hansen, S. Braekkan, 2018, Journal of thrombosis and haemostasis : JTH.

Impact of preanalytical conditions on plasma concentration and size distribution of extracellular vesicles using Nanoparticle Tracking Analysis

J. Hansen, P. Webster, S. Brækkan, 2018, Scientific Reports.

"A rapid, sensitive, and specific assay to measure tissue factor activity based on chromogenic determination of thrombin generation": reply.

J. Hansen, O. Snir, B. Østerud, 2023, Journal of thrombosis and haemostasis : JTH.